INCB024360

Incyte's 'IDO' Cancer Immunotherapy Causes Investor Scrum at ASCO '14
TheStreet.com
Mon, 06/2/14 - 06:09 pm
Incyte
ASCO
immunotherapy
melanoma
INCB024360